Skip to main content
OpenTrials

Clinical trial condition

Retinal Degeneration

Explore clinical trials studying Retinal Degeneration. Study availability and eligibility vary by location and protocol.

49 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Retinal Degeneration trial results

Completed

Dual Wavelength OCT

NCT03843840

Conditions
AMD, Cardiovascular Diseases, Diabetes Complications, +10 more
Locations
  • Moorfields Eye Hospital NHS Foundation Trust, 162 City Road London, United Kingdom
View Trial Details
Completed

First in Human Study to Evaluate the Safety and Tolerability of GEM103 in Geographic Atrophy Secondary to Dry Age Related Macular Degeneration

NCT04246866

Conditions
Dry Age-related Macular Degeneration, Eye Diseases, Eye Diseases, Hereditary, +5 more
Locations
  • Associated Retina Consultants Phoenix, Arizona, United States
  • Retinal Consultants of Arizona Phoenix, Arizona, United States
  • California Retina Consultants Bakersfield, California, United States
  • Retina Vitreous Associates Beverly Hills, California, United States
View Trial Details
Completed

Safety and Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients

NCT01024803

Conditions
Blindness, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, +13 more
Locations
  • Helmut Sachs, MD, PD Dresden, Germany
  • Johann Roider, MD, Prof. Kiel, Germany
  • Karl-Ulrich Bartz-Schmidt, MD, Prof. Tübingen, Germany
  • Miklos Resch, MD, PhD Budapest, Hungary
View Trial Details
Completed

Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD)

NCT01024998

Conditions
Age-Related Maculopathies, Age-Related Maculopathy, Eye Diseases, +13 more
Locations
  • investigational site number 03WilmerEy Baltimore, Maryland, United States
  • investigational site number 02Ophthalm Boston, Massachusetts, United States
  • investigational site number 01UMassMem Worcester, Massachusetts, United States
  • investigational site number 05RetinaCo Slingerlands, New York, United States
View Trial Details

Related conditions